|
|
Volumn 31, Issue 30, 2013, Pages 3845-3846
|
|
Reply to N. Rompoti et al
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B RAF KINASE;
VEMURAFENIB;
IMIDAZOLE DERIVATIVE;
INDOLE DERIVATIVE;
OXIME;
PROTEIN KINASE INHIBITOR;
SULFONAMIDE;
BONE METASTASIS;
BRAIN METASTASIS;
CANCER RADIOTHERAPY;
DISEASE SEVERITY;
HUMAN;
INGUINAL LYMPH NODE;
LETTER;
LYMPH NODE METASTASIS;
METASTATIC MELANOMA;
PRIORITY JOURNAL;
RADIATION DERMATITIS;
RADIATION DOSE;
RADIATION EXPOSURE;
RADIATION FIELD;
SKIN TOXICITY;
CONTACT DERMATITIS;
DRUG ANTAGONISM;
FEMALE;
MALE;
MELANOMA;
NOTE;
RADIATION INJURY;
ANTAGONISTS AND INHIBITORS;
DERMATITIS, CONTACT;
RADIATION INJURIES;
DERMATITIS, CONTACT;
FEMALE;
HUMANS;
IMIDAZOLES;
INDOLES;
MALE;
MELANOMA;
OXIMES;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS B-RAF;
RADIATION INJURIES;
SULFONAMIDES;
|
|
EID: 84891521493
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2013.51.8936 Document Type: Letter |
|
Times cited : (1)
|
|
References (4)
|
